Rosubus Gold Rosuvastatin, Aspirin and Clopidogrel Capsules

  • Product Name : Rosubus Gold Rosuvastatin, Aspirin and Clopidogrel Capsules
  • Category : Anticoagulant
  • Manufacturer Name : Globus Labs
  • Trade Name : Rosubus Gold
  • Available Dosage :
  • Packing : Strip
  • Pack Insert/Leaflet : 1 Pack/100 Capsules
  • Ingredients : Aspirin, Rosuvastatin, Clopidogrel
  • Formulation : Capsule
  • Therapeutic use : prevention of heart attack, stroke and treatment of peripheral vascular disease
  • Production Capacity : 100000

Description:-

Introduction to Rosubus Gold Rosuvastatin, Aspirin, and Clopidogrel Capsules

Rosubus Gold, offered by Lexaro Healthcare, combines Rosuvastatin, Aspirin, and Clopidogrel in a specialized capsule formulation. Each capsule is meticulously formulated with a focus on quality and efficacy.


Uses of Rosubus Gold Rosuvastatin, Aspirin, and Clopidogrel Capsules

Rosubus Gold is indicated for the management of cardiovascular conditions, including prevention of cardiovascular events such as heart attacks and strokes. It is prescribed to reduce cholesterol levels, prevent blood clot formation, and improve overall cardiovascular health.


Benefits of Rosubus Gold Rosuvastatin, Aspirin, and Clopidogrel Capsules

Comprehensive cardiovascular protection with a triple combination therapy.

Rosuvastatin lowers LDL cholesterol ("bad" cholesterol) and triglycerides, while increasing HDL cholesterol ("good" cholesterol).

Aspirin inhibits platelet aggregation, reducing the risk of blood clot formation.

Clopidogrel further inhibits platelet function, enhancing antiplatelet effects and reducing thrombotic events.


Mechanism of Action of Rosubus Gold Rosuvastatin, Aspirin, and Clopidogrel Capsules

Rosuvastatin works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis, thereby lowering cholesterol levels in the blood. Aspirin inhibits cyclooxygenase enzymes, reducing thromboxane A2 production and inhibiting platelet aggregation. Clopidogrel inhibits ADP receptors on platelets, further preventing platelet activation and aggregation.